SAM #HT940226F0008

Award for Independent Due Diligence and Feasibility Assessment for Military Domestic Pharmaceutical Manufacturing and Supply Chain Resilience

This award notice announces a contract by the Defense Health Agency (DHA) for urgent consulting and assessment services to strengthen domestic pharmaceutical manufacturing for military needs. - Awarded to Accenture Federal Services LLC via a sole-source task order under the DLA JETS IDIQ contract - Focused on independent technical, regulatory, and economic due diligence for domestic production of military-essential medications - Addresses vulnerabilities in the supply chain for Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs), which are currently sourced from foreign suppliers - Services include supply chain mapping, feasibility assessments, proposal evaluation, and strategic recommendations - No specific OEMs or pharmaceutical manufacturers are named; the award is for consulting and assessment services - Sole-source procurement justified by urgent national security requirements - Period of performance is 10 weeks from award date - No product purchases; only professional services are included

Description

1. An immediate, urgent action was required to support the Assistant Secretary of War for Health Affairs (ASW(HA)) in evaluating and securing the domestic manufacturing base for military-essential medications. The Department of War (DoW) currently faces an existential supply chain vulnerability, as the Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) for the military's top 25 combat-essential medications are sourced almost entirely from foreign sources.

2. This effort requires independent technical, regulatory, and economic due diligence assessments of proposed domestic pharmaceutical manufacturing solutions. The end result will provide a strategic roadmap and actionable financial underwriting analysis to ensure the DoD can rapidly secure its essential medical supply chain without relying on foreign entities.

3. The Government has determined that the need to ensure the DoD can rapidly secure its essential medical supply chain without relying on foreign entities is of such an unusual and compelling urgency (FAR 16.507-6(b)(1) (RFO)) that the Government has pursued a sole source procurement for the services described above.

View original listing